Galantos Genetics GmbH

Joh.-Joachim-Becher-Weg 30 a
55128
Germany

Phone: 00496131-720620
Fax: 004961313929293
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: CSI Mainz

Description:

The Lab at the Campus on the University of Mainz

Galantos Genetics is a special laboratory run by academics that not only provide quality service and genetic testing, but also create new improved forms of genetic and forensic tests. The genetic tests are carried out in Mainz ; the new research and creation of tests are a close cooperation with the American based company Independent Forensics.

Paternity Test lab. ISO 17025 accreditation for paternity testing https://www.galantos.de

Qualification

All tests that are carried out by Galantos Genetics are subject to strict protocols and SOPs (standard operating procedures). The company fulfills all usual German and European standards. Our Project Manager Dr. Karl Reich is accredited by the American Standards of the NFSTC the AABB (American Association Of Blood Banks ) the DOH ( State of New York, Department of Health )and the FBI. Galantos has successfully took part in the GEDNAP interlaboratory comparisons.

Founder

Galantos Genetics GmbH is a specialist company for genetic tests. The company is the brainchild of University Professor Doctor Alfred Maelicke from the specialist area of medicine at the University of Mainz , the molecular biologist and Managing Director of the American company Independent Forensics, Dr. Karl Reich and other specialist scientists.

Management and Staff

The management of the company is led by Dr. Ulrike Schacker and Martin Schatzl. Other scientists are also a part of our specialist staff.

Location

Galantos Genetics enjoys one of the most modern laboratories with up to date equipment, which is on the Campus of the Johannes-Gutenberg-University of Mainz

_{^{keywords,products : RSID Rapid Stain Identification, paternity testing, vaterschaftstest, Sperm HY-LITER}}

Last update of this entry: March 12, 2024